Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigurdur Y Kristinsson

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?Sigurdur Y Kristinsson, Ola Landgren
Blood|March 29, 2011
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategiesNeha Korde, Sigurdur Y Kristinsson, Ola Landgren
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemiaSigurdur Y Kristinsson, Magnus Björkholm, Ola Landgren
The New England Journal of Medicine|November 1, 2013
Treatment for high-risk smoldering myelomaSigurdur Y Kristinsson, Erik Holmberg, Cecilie Blimark
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditionsElisabet E Manasanch, Sigurdur Y Kristinsson, Ola Landgren
Mayo Clinic Proceedings|March 3, 2010
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinicIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based studyIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.
Blood|July 23, 2013
No familial aggregation in chronic myeloid leukemiaMagnus Björkholm, Sigurdur Y Kristinsson, Ola Landgren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune diseaseOla Landgren, Ruth M Pfeiffer, Sigurdur Y Kristinsson, et al.
BMJ Open|January 24, 2016
Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trendsRamón Vélez, Ingemar Turesson, Ola Landgren, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
What causes Waldenström's macroglobulinemia: genetic or immune-related factors, or a combination?Sigurdur Y Kristinsson, Ola Landgren
Blood|March 29, 2011
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategiesNeha Korde, Sigurdur Y Kristinsson, Ola Landgren
Clinical Lymphoma, Myeloma & Leukemia|March 16, 2013
Survival in monoclonal gammopathy of undetermined significance and Waldenström macroglobulinemiaSigurdur Y Kristinsson, Magnus Björkholm, Ola Landgren
The New England Journal of Medicine|November 1, 2013
Treatment for high-risk smoldering myelomaSigurdur Y Kristinsson, Erik Holmberg, Cecilie Blimark
Clinical Lymphoma, Myeloma & Leukemia|March 12, 2013
Etiology of Waldenström macroglobulinemia: genetic factors and immune-related conditionsElisabet E Manasanch, Sigurdur Y Kristinsson, Ola Landgren
Mayo Clinic Proceedings|March 3, 2010
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinicIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based studyIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.
Blood|July 23, 2013
No familial aggregation in chronic myeloid leukemiaMagnus Björkholm, Sigurdur Y Kristinsson, Ola Landgren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2010
Survival patterns in patients with Hodgkin's lymphoma with a pre-existing hospital discharge diagnosis of autoimmune diseaseOla Landgren, Ruth M Pfeiffer, Sigurdur Y Kristinsson, et al.
BMJ Open|January 24, 2016
Incidence of multiple myeloma in Great Britain, Sweden, and Malmö, Sweden: the impact of differences in case ascertainment on observed incidence trendsRamón Vélez, Ingemar Turesson, Ola Landgren, et al.
Pageof 10